Blood pressure lowering after acute stroke

In this large trial of patients with acute stroke (ischemic or hemorrhagic) and systolic blood pressure >140 mmHg, they were randomized to candesartan or placebo for 7 days. At 6 months, there was no difference in recurrent vascular events, but the candesartan group had significantly worse functional outcomes. Blood pressure lowering with candesartan during acute stroke is not beneficial (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment